Inogen Inc (INGN) — 分析摘要
Inogen Inc（INGN）的市值为170.84百万美元，最近一年的营收同比增长了+5.9%。净利润率为-7.7%。当前市盈率为-6.9倍。
核心要点
- 营收同比变化+5.9%
- 净利润率-7.7%
- 市盈率-6.9倍
与ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES板块的其他公司相比，INGN的营收增长为+5.9%，市盈率为-6.9倍。
Inogen Inc (INGN)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号，应与估值结果一并解读。
营业利润率为 -10.7% — 经营亏损显著
最新报表显示自由现金流为负。
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
行业
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
员工人数
753
总部
BEVERLY, MA
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。